Grail says over 400 patients incorrectly informed they may have cancer
June 2 (Reuters) – Cancer test maker Grail Inc (GRAL.O) said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. … Read More